Atlas Trials

Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation

Clinical trial NCT03474614 · TERMINATED

Trial details

NCT number
NCT03474614
Sponsor
St. Joseph's Hospital and Medical Center, Phoenix
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cerebral Cavernous Malformations
Start date
2018-01-24
Primary completion
2021-02-11
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.